Stay updated on Pembrolizumab for Mycosis Fungoides Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.

Latest updates to the Pembrolizumab for Mycosis Fungoides Clinical Trial page
- Check4 days agoChange DetectedAn error page (403 Forbidden) is now shown instead of the study record content. This indicates an access restriction rather than an update to the study details.SummaryDifference20%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 on the study page, indicating a minor backend/template update. No study data or displayed information appears to be affected.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a new revision label, Revision: v3.6.5, replacing the prior Revision: v3.6.4, indicating a recent page update.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision entry updated from v3.6.3 to v3.6.4, signaling a new page revision. The update does not alter the visible content or functionality of the study page.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision was updated to v3.6.3, indicating a newer release of the page. This reflects a minor update to the page's documentation or formatting rather than substantive changes to the study details.SummaryDifference0.1%

- Check90 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a maintenance update; core study details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Mycosis Fungoides Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.